Related references
Note: Only part of the references are listed.Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells
Stefano Gigli et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea
Ozlem Yoldas et al.
BALKAN MEDICAL JOURNAL (2016)
Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway
Giuseppe Esposito et al.
FRONTIERS IN PHARMACOLOGY (2016)
A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole
Amos Adler et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
A small-molecule antivirulence agent for treating Clostridium difficile infection
Kristina Oresic Bender et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era
Christopher R. Polage et al.
JAMA INTERNAL MEDICINE (2015)
Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
Claire Nour Abou Chakra et al.
PLOS ONE (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
A. Sarah Walker et al.
CLINICAL INFECTIOUS DISEASES (2013)
Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
Sailajah Janarthanan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Current Status of Clostridium difficile Infection Epidemiology
Fernanda C. Lessa et al.
CLINICAL INFECTIOUS DISEASES (2012)
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics
Marjolein P. M. Hensgens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Reducing the risk of severe complications among patients with Clostridium difficile infection
Kamran Manek et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Clinical Risk Factors for Severe Clostridium difficile-associated Disease
Timothy J. Henrich et al.
EMERGING INFECTIOUS DISEASES (2009)
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates
T Åkerlund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces
J Freeman et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Share Paper
